Overview
Antithrombotic Therapy in patients with Acute Coronary Syndromes
Elderly patients with Heart Disease
Biomarkers in Acute Coronary Syndromes and Atrial Fibrillation
Thrombosis and Anticoagulation and novel antithrombotic agents
Metabolomics in Cardiovascular Medicine
Current Appointments & Affiliations
Professor of Medicine
·
2021 - Present
Medicine, Cardiology,
Medicine
Member in the Duke Clinical Research Institute
·
2009 - Present
Duke Clinical Research Institute,
Institutes and Centers
Recent Publications
Association Between the 2022 AHA/ACC/HFSA Heart Failure Staging and Cardiovascular and Kidney Outcomes in Patients With Diabetes and Kidney Disease: A Post Hoc Analysis of the SCORED Randomized Controlled Trial.
Journal Article Circ Heart Fail · January 22, 2026 BACKGROUND: The 2022 American Heart Association/American College of Cardiology/Heart Failure Society of America heart failure (HF) classification incorporates cardiac biomarkers to identify early risk of HF. The HF stages may also guide the prognosis and m ... Full text Link to item CiteIVUS, OCT, or Angiography as Guidance for PCI in Complex Coronary Artery Lesions: Network Meta-Analysis of Randomized Controlled Trials.
Journal Article JACC Cardiovasc Interv · January 12, 2026 BACKGROUND: Intravascular imaging-guided percutaneous coronary intervention (PCI) reduces cardiovascular events compared with angiography-guided PCI alone. However, there is a paucity of data comparing these approaches in patients with complex coronary art ... Full text Link to item CiteAlbiglutide and atrial fibrillation in patients with Type 2 diabetes and established cardiovascular disease: insights from the Harmony Outcomes trial.
Journal Article Eur J Prev Cardiol · January 6, 2026 AIMS: Atrial fibrillation and flutter (AF) are common in patients with Type 2 diabetes and are associated with worse outcomes. METHODS AND RESULTS: Harmony Outcomes was a multi-centre, event-driven, double-blind, placebo-controlled trial comparing the effe ... Full text Link to item CiteRecent Grants
Protocol CS12_CEC
Clinical TrialPrincipal Investigator · Awarded by Ionis Pharmaceuticals Inc · 2025 - 2029A PROGRAM OF THREE STUDIES IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS
Clinical TrialPrincipal Investigator · Awarded by Parexel International LLC · 2021 - 2029Priovant BREPO
Clinical TrialPrincipal Investigator · Awarded by Priovant Therapeutics, Inc · 2022 - 2029View All Grants
Education, Training & Certifications
Duke University, School of Medicine ·
2009
M.H.S.
Paulista Medical School, University of Sao Paulo (Brazil) ·
2006
Ph.D.
University of Santo Amaro (Brazil) ·
2001
M.D.